This finding was also demonstrated in another study that showed a direct correlation between Cx43 and ER/PR status in human breast carcinoma samples, however, it did not address Cx43 expression in TNBC nor in HER2+ samples, the most aggressive subtypes of breast cancers [51]. The gene discussed is ESR1; the disease is breast cancer.